GHD Cancer Institute

Greenville, South Carolina 29605

0 studies enrolling now · 1 studies all time

What they study most

Diffuse Large B-Cell Lymphoma Refractory, Diffuse Large B-cell Lymphoma Recurrent

Studies at this site

• Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Completed